Literature DB >> 22444600

Comparison of the course of substance use disorders among individuals with and without generalized anxiety disorder in a nationally representative sample.

Jessica F Magidson1, Shang-Min Liu, C W Lejuez, Carlos Blanco.   

Abstract

Generalized anxiety disorder (GAD) and substance use disorders (SUDs) are highly comorbid, and GAD-SUD comorbidity is associated with a host of poor psychosocial outcomes, including higher rates of hospitalization, disability, functional impairment, and inferior GAD and SUD treatment outcomes. Despite the noted severity of this group and clinical implications, current research is limited in a few distinct ways; studies have rarely utilized a longitudinal design and non-treatment seeking individuals to examine how GAD comorbidity impacts SUD outcomes over time. The current study utilized a nationally representative sample of individuals in the U.S. assessed in the National Epidemiological Survey on Alcohol and Related Conditions (NESARC) at Wave 1 (2001-2002) and Wave 2 (2004-2005), comparing individuals who met criteria for both DSM-IV past year GAD and SUD (n = 286) and those who met criteria for past year SUD only without GAD (n = 5730) at Wave 1. Results indicated that GAD-SUD individuals were significantly more severe than the SUD only group across almost all outcomes assessed (with the exception of alcohol frequency); individuals with GAD-SUD had a more severe psychiatric history, worse health-related quality of life at both waves, greater incidence of new Axis I disorders, higher rates of treatment seeking, and greater self-reported drug use at the follow up. The current study is the first to compare individuals with SUD with and without comorbid GAD over time using a nationally representative sample. Findings further support the clinical severity of this group and suggest the need for GAD-SUD treatment options. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22444600      PMCID: PMC3334401          DOI: 10.1016/j.jpsychires.2012.02.011

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  27 in total

1.  Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Bridget F Grant; Deborah S Hasin; Frederick S Stinson; Deborah A Dawson; W June Ruan; Risë B Goldstein; Sharon M Smith; Tulshi D Saha; Boji Huang
Journal:  Psychol Med       Date:  2005-10-05       Impact factor: 7.723

2.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Olga Demler; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

3.  Concordance of DSM-IV alcohol and drug use disorder criteria and diagnoses as measured by AUDADIS-ADR, CIDI and SCAN.

Authors:  L B Cottler; B F Grant; J Blaine; V Mavreas; C Pull; D Hasin; W M Compton; M Rubio-Stipec; D Mager
Journal:  Drug Alcohol Depend       Date:  1997-09-25       Impact factor: 4.492

4.  The structure of common mental disorders.

Authors:  R F Krueger
Journal:  Arch Gen Psychiatry       Date:  1999-10

5.  Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Kevin P Conway; Wilson Compton; Frederick S Stinson; Bridget F Grant
Journal:  J Clin Psychiatry       Date:  2006-02       Impact factor: 4.384

6.  Perceived need and help-seeking in adults with mood, anxiety, or substance use disorders.

Authors:  Ramin Mojtabai; Mark Olfson; David Mechanic
Journal:  Arch Gen Psychiatry       Date:  2002-01

7.  The impact of comorbid anxiety and depression on alcohol treatment outcomes.

Authors:  Lucy Burns; Maree Teesson; Katy O'Neill
Journal:  Addiction       Date:  2005-06       Impact factor: 6.526

8.  Comorbidity of generalized anxiety disorder and alcohol use disorders among individuals seeking outpatient substance abuse treatment.

Authors:  Joshua P Smith; Sarah W Book
Journal:  Addict Behav       Date:  2009-08-07       Impact factor: 3.913

9.  The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample.

Authors:  Bridget F Grant; Deborah A Dawson; Frederick S Stinson; Patricia S Chou; Ward Kay; Roger Pickering
Journal:  Drug Alcohol Depend       Date:  2003-07-20       Impact factor: 4.492

10.  Prevalence, correlates, disability, and comorbidity of DSM-IV narcissistic personality disorder: results from the wave 2 national epidemiologic survey on alcohol and related conditions.

Authors:  Frederick S Stinson; Deborah A Dawson; Risë B Goldstein; S Patricia Chou; Boji Huang; Sharon M Smith; W June Ruan; Attila J Pulay; Tulshi D Saha; Roger P Pickering; Bridget F Grant
Journal:  J Clin Psychiatry       Date:  2008-07       Impact factor: 4.384

View more
  10 in total

1.  Characterizing Anxiety Among Individuals Receiving Treatment for Alcohol and Substance Use Disorders.

Authors:  Lisa H Domenico; Ben Lewis; Mythili Hazarika; Sara Jo Nixon
Journal:  J Am Psychiatr Nurses Assoc       Date:  2017-11-10       Impact factor: 2.385

Review 2.  Treatment of co-occurring anxiety disorders and substance use disorders.

Authors:  R Kathryn McHugh
Journal:  Harv Rev Psychiatry       Date:  2015 Mar-Apr       Impact factor: 3.732

3.  Triple comorbid trajectories of tobacco, alcohol, and marijuana use as predictors of antisocial personality disorder and generalized anxiety disorder among urban adults.

Authors:  Judith S Brook; Jung Yeon Lee; Elizabeth Rubenstone; David W Brook; Stephen J Finch
Journal:  Am J Public Health       Date:  2014-06-12       Impact factor: 9.308

4.  Network Analysis of DSM Symptoms of Substance Use Disorders and Frequently Co-Occurring Mental Disorders in Patients with Substance Use Disorder Who Seek Treatment.

Authors:  Edith López-Toro; Casper J H Wolf; Rafael A González; Wim van den Brink; Arnt Schellekens; María C Vélez-Pastrana
Journal:  J Clin Med       Date:  2022-05-19       Impact factor: 4.964

5.  Testing the drug substitution switching-addictions hypothesis. A prospective study in a nationally representative sample.

Authors:  Carlos Blanco; Mayumi Okuda; Shuai Wang; Shang-Min Liu; Mark Olfson
Journal:  JAMA Psychiatry       Date:  2014-11       Impact factor: 21.596

6.  Association of comorbid generalized anxiety disorder and alcohol use disorder symptoms with health-related quality of life: results from the National Epidemiological Survey on Alcohol and Related Conditions.

Authors:  Bernadette A Cullen; Lareina N La Flair; Carla L Storr; Kerry M Green; Anika A H Alvanzo; Ramin Mojtabai; Lauren R Pacek; Rosa M Crum
Journal:  J Addict Med       Date:  2013 Nov-Dec       Impact factor: 3.702

7.  Association between severity of illicit drug dependence and quality of life in a psychosocial care center in BRAZIL: cross-sectional study.

Authors:  Selva Rios Campêlo; Maria Alves Barbosa; Danilo Rocha Dias; Camila Cardoso Caixeta; Cláudio Rodrigues Leles; Celmo Celeno Porto
Journal:  Health Qual Life Outcomes       Date:  2017-11-17       Impact factor: 3.186

8.  Amplification of Positivity Therapy for Co-occurring Alcohol Use Disorder with Depression and Anxiety Symptoms: Pilot Feasibility Study and Case Series.

Authors:  Elisabeth Akeman; Evan White; Kate Wolitzky-Taylor; Jessica Santiago; Timothy J McDermott; Danielle C DeVille; Jennifer L Stewart; Martin Paulus; Charles T Taylor; Robin L Aupperle
Journal:  Behav Modif       Date:  2021-07-12

Review 9.  Management of chronic pain with chronic opioid therapy in patients with substance use disorders.

Authors:  Yu-Ping Chang; Peggy Compton
Journal:  Addict Sci Clin Pract       Date:  2013-12-16

10.  Substance abuse and personality disorder comorbidity in adolescent outpatients: are girls more severely ill than boys?

Authors:  Hans Ole Korsgaard; Svenn Torgersen; Tore Wentzel-Larsen; Randi Ulberg
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2016-04-11       Impact factor: 3.033

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.